真菌病治疗原则及抗真菌药物介绍(更新版)精选.ppt

* This electron micrograph shows the fungistatic effect of the azoles. There is reduced budding from the parent cells. * （体外对曲霉有杀菌作用） * （体外对曲霉有杀菌作用） * * * * * * 出处：各产品说明书 * 出处：各产品说明书 * 出处：卡泊芬净，两性霉素B脱氧胆酸盐国内说明书；Amphotec美国说明书 SPORANOX? (itraconazole) Injection/Oral Solution is indicated for empiric therapy of febrile neutropenic patients with suspected fungal infections. SPORANOX? (itraconazole) Injection is also indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: Blastomycosis, 2. Histoplasmosis, 3. Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy. SPORANOX? (itraconazole) Injection/Oral Solution is indicated for empiric therapy of febrile neutropenic patients with suspected fungal infections. SPORANOX? (itraconazole) Oral Solution is also indicated for the treatment of oropharyngeal and esophageal candidiasis. SPORANOX? (itraconazole) Capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: 1. Blastomycosis, 2. Histoplasmosis, 3. Aspergillosis, in patients who are intolerant of or who are refractory to amphotericin B therapy. SPORANOX? Capsules are also indicated for the treatment of the following fungal infections in non-immunocompromised patients: 1. Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium), and 2. Onychomycosis of the fingernail due to dermatophytes (tinea unguium). * * 按中国和美国说明书填入适应症 * * * 出处：卡泊芬净美国说明书 * 出处：卡泊芬净美国说明书 * 出处：伊曲康唑美国说明书， * 出处：伊曲康唑美国说明书， * 出处：伊曲康唑美国说明书， * * 仅供北京协和医院特需医疗部科内会议使用，不作为推广材料 * 仅供北京协和医院特需医疗部科内会议使用，不作为推广材料 * 仅供北京协和医院特需医疗部科内会议使用，不作为推广材料 * 仅供北京协和医院特需医疗部科内会议使用，不作为推广材料 * 仅供北京协和医院特需医疗部科内会议使用，不作为推广材料 * 仅供北京协和医院特需医疗部科内会议使用，不作为推广材料 * 仅供北京协和医院特需医疗部科内会议使用，不作为推广材料 * 仅供北京协和医院特需医疗部科内会议使用，不作为推广材料 * 抗真菌治疗失败的相关因素 抗真菌药物对致病菌活性不佳或组织浓度低 给药剂量不足 药物吸收障碍 药物间相互作用 患者不遵守治疗方案 局部感